If you’re new to our page, here’s what Ancora Heart is focused on. We’re conducting a global pivotal clinical trial called the CORCINCH-HF Study for the #AccuCinch Ventricular Restoration System – an investigational device for #heartfailure. It is designed to improve the structure and function of the heart and may help reduce symptoms, improve quality of life and potentially increase life expectancy. You can learn more about our #clinicaltrial here: https://lnkd.in/eQ-kAmw7. #cardiology #clinicaltrials #structuralheart
Ancora Heart, Inc.
Medical Equipment Manufacturing
Santa Clara, California 3,350 followers
A fundamentally different and innovative therapy for patients with heart failure
About us
Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company’s proprietary AccuCinch® Ventricular Restoration System is the first completely percutaneous device designed to restore the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of systolic heart failure. It has come to our attention that an unknown entity is impersonating our organization and extending illegitimate job offers via email, purportedly in an attempt to defraud intended applicants. Please be advised that these email solicitations appear to be part of a fake job scheme. For additional information, please see https://www.fbi.gov/contact-us/field-offices/elpaso/news/press-releases/fbi-warns-cyber-criminals-are-using-fake-job-listings-to-target-applicants-personally-identifiable-information. Authorized Ancora Heart employees will reach out to potential candidates directly via telephone or email from ancoraheart.com but will never issue questionnaires or request personal information. Job offers will only be extended after a thorough interview process and multiple interactions with Ancora Heart staff members. When communicating, please be very cautious of fictitious email addresses.
- Website
-
http://www.ancoraheart.com/
External link for Ancora Heart, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Santa Clara, California
- Type
- Privately Held
Locations
-
Primary
4001 Burton Dr
Santa Clara, California 95054, US
Employees at Ancora Heart, Inc.
-
Matt Merkert
Business/Marketing Executive | Health & Med Tech | Leadership, Product & Marketing Management, Operational Excellence
-
Jeff Closs
President and CEO at Ancora Heart, Inc.
-
Sue Hoffman
-
Erik Martz, BS, MS
A skilled field clinical and product development engineer, having experience with transcatheter structural heart systems and orthopedic devices.
Updates
-
A big thank you to Prof. Alena Kurlianskaya for an insightful presentation about the #AccuCinch Ventricular Restoration System for HFrEF patients! The presentation was part of the session on ‘Interventional Therapies for Heart Failure’ and was conducted during the Advanced Valve Therapies conference at the ONASSIS CARDIAC SURGERY CENTER in Athens, Greece. #heartfailure #cardiology #structuralheart
-
-
Continuing our progress for the CORCINCH-HF #clinicaltrial with the Institute of Cardiovascular Diseases, Vojvodina! Congratulations to Prof. Milovan Petrovic, Drs. Mila Kovacevic, Aleksandra Ilić, Dragana Dabovic and the entire team for their first #AccuCinch Ventricular Restoration System implant for patients with #heartfailure. Thanks again to Dr. Oleg Polonetsky for proctoring! #cardiology #clinicaltrials
-
-
Congratulations to the stellar team from the Institute for Cardiovascular Diseases "Dedinje", Serbia for completing the 1st #AccuCinch Ventricular Restoration System implant for #heartfailure as part of the CORCINCH-HF #clinicaltrial! The team includes Drs. Dragana Kosevic, Mihajlo Farkic, Dragan Topic, Dragana Unić-Stojanović, Prof. Aleksandra Nikolić and research coordinator Juliana Djuričić – thank you for your hard work furthering this innovative treatment option! A special thank you to Dr. Oleg Polonetsky for being the medical proctor. #cardiology #clinicaltrial
-
-
We’re pleased to have completed training the Ascension Via Christi Health team with the #AccuCinch Ventricular Restoration System last week! Congrats to Drs. Bassem Chehab, MD and Brett Grizzell, and Grace Haney who will help advance the CORCINCH-HF #clinicaltrial at this center! #cardiology #clinicaltrials
-
-
Thank you to Dr. Mark Reisman for presenting 24-month outcomes with the #AccuCinch Ventricular Restoration System for the first time at #CSIFrankfurt2024! We’re energized by the results and look forward to sharing more data to help patients with #heartfailure. CSI congress
-
-
We’re looking forward to an exciting presentation by Dr. Mark Reisman about the #AccuCinch Ventricular Restoration System and the CORCINCH-HF pivotal #clinicaltrial at #CSIFrankfurt2024! Join us on June 19 at 12:20 p.m. CST in the Yellow Rom for a focus workshop on Ventricular Restoration Therapies including the AccuCinch System. CSI congress
-
-
We’re thrilled to share that we just completed the 200th #AccuCinch Ventricular Restoration System procedure in a #heartfailure patient. Congratulations to Drs. Jozef Bartunek, Marc Vanderheyden and Martin Penicka, the OLV Ziekenhuis Aalst-Asse-Ninove team, along with proctor Dr. Oleg Polonetsky for being the team to place this milestone implant! This case marks the 200th AccuCinch implant over the entire clinical experience of current and previous studies, globally. #Cardiology #ClinicalTrials
-
-
Congratulations to the team from Providence Sacred Heart in Spokane, WA! Last week, Drs. Philip Huber, Erik Condon and Jonathan D. Hansen, MD MPH were successfully trained with the #AccuCinch Ventricular Restoration System for patients with #heartfailure. We look forward to working with this team and their medical center to advance the CORCINCH-HF #clinicaltrial. #cardiology #clinicaltrials
-
-
Thanks to Dr. Ulrich Jorde for an insightful presentation about the #AccuCinch Ventricular Restoration System and CORCINCH-HF #clinicaltrial for patients with #heartfailure at the #NYValves2024 conference. We appreciated his presentation and enjoyed all the productive discussions at the meeting!
-